Sherbrooke Park Advisers’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,962
Closed -$98.1K 192
2025
Q3
$98.1K Buy
10,962
+16
+0.1% +$148 0.05% 450
2025
Q2
$103K Sell
10,946
-25,203
-70% -$222K 0.04% 459
2025
Q1
$392K Buy
+36,149
New +$364K 0.18% 206
2024
Q4
Sell
-65,964
Closed -$741K 733
2024
Q3
$741K Buy
65,964
+46,962
+247% +$499K 0.17% 166
2024
Q2
$190K Sell
19,002
-58,869
-76% -$598K 0.03% 777
2024
Q1
$896K Buy
+77,871
New +$661K 0.17% 177

Other funds holding AHCO

Sherbrooke Park Advisers's AHCO Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of AdaptHealth (AHCO) in Q4 2025, closing a stake of 10,962 shares — an estimated $98.1K sold.

Sherbrooke Park Advisers first reported a position in AHCO in Q1 2024 and held it in 6 quarters. The position peaked at $896K in Q1 2024. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining AdaptHealth position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 10,962 AdaptHealth shares in Q4 2025, an estimated $98.1K.
  • Sherbrooke Park Advisers first reported a position in AdaptHealth in Q1 2024 and held it in 6 quarters.
  • Sherbrooke Park Advisers's AdaptHealth position peaked at $896K in Q1 2024.
  • 231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.